Publications by authors named "Jason G Gall"

Claim this Profile
M
Multi-attribute monitoring (MAM) methodology for glycosylated subunit vaccines.
Asif Shajahan, Lisa M Jenkins, Nathan Barefoot, Darielys Maldonado, Jeremy J Wolff, Jason G Gall

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody.
Sharana Mahomed, Nonhlanhla N Mkhize, Leonid A Serebryannyy, Tandile Hermanus, Prudence Kgagudi, Jason G Gall

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults.
Richard L Wu, Katherine V Houser, Martin R Gaudinski, Alicia T Widge, Seemal F Awan, Jason G Gall

Lancet HIV· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of degradation for sulfo-SIAB, SM(PEG), and sulfo-GMBS by RPLC-UV analysis.
Melissa Resto, Alison Vinitsky, Nicole A Schneck, Jeremy J Wolff, Asif Shajahan, Jason G Gall

J Pharm Biomed Anal· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivo.
John Misasi, Ronnie R Wei, Lingshu Wang, Amarendra Pegu, Chih-Jen Wei, Jason G Gall

Sci Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.
Joseph P Casazza, Amelia R Hofstetter, Pamela J M Costner, LaSonji A Holman, Cynthia S Hendel, Jason G Gall

NPJ Vaccines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.
Kassoum Kayentao, Aissata Ongoiba, Anne C Preston, Sara A Healy, Zonghui Hu, Jason G Gall

N Engl J Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.
Seemal F Awan, Amarendra Pegu, Larisa Strom, Cristina A Carter, Cynthia S Hendel, Jason G Gall

JCI Insight· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaic quadrivalent influenza vaccine single nanoparticle characterization.
Rong Sylvie Yang, Maria Traver, Nathan Barefoot, Tyler Stephens, Casper Alabanza, Jason G Gall

Sci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Betty Mwesigwa, Katherine V Houser, Amelia R Hofstetter, Ana M Ortega-Villa, Prossy Naluyima, Jason G Gall

Lancet Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
Alec W Freyn, Caroline Atyeo, Patricia L Earl, Jeffrey L Americo, Gwo-Yu Chuang, Jason G Gall

Sci Transl Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of strain-specific hemagglutinin trimers in mosaic quadrivalent influenza nanoparticle vaccine by ELISA.
Casper Alabanza, Victor Gavrilov, Taylor Scott, Rong Sylvie Yang, Daniel B Gowetski, Jason G Gall

Vaccine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases.
Adam S Olia, Cheng Cheng, Tongqing Zhou, Andrea Biju, Darcy R Harris, Jason G Gall

iScience· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-Specific Fluorescent Labeling of Hemagglutinin-Specific Antigen Binding Fragment through Amine Chemistry Revealed by Mass Spectrometry.
Guozhang Zou, Vera B Ivleva, Jeremy J Wolff, Rong Sylvie Yang, Casper Alabanza, Jason G Gall

J Am Soc Mass Spectrom· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Alicia T Widge, Amelia R Hofstetter, Katherine V Houser, Seemal F Awan, Grace L Chen, Jason G Gall

Sci Transl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Melinda J Hamer, Katherine V Houser, Amelia R Hofstetter, Ana M Ortega-Villa, Christine Lee, Jason G Gall

Lancet· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1.
Li Ou, Krishana Gulla, Andrea Biju, Daniel W Biner, Tatsiana Bylund, Jason G Gall

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
Richard L Wu, Azza H Idris, Nina M Berkowitz, Myra Happe, Martin R Gaudinski, Jason G Gall

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.
Katherine V Houser, Martin R Gaudinski, Myra Happe, Sandeep Narpala, Raffaello Verardi, Jason G Gall

EClinicalMedicine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
Joseph P Casazza, Evan M Cale, Sandeep Narpala, Galina V Yamshchikov, Emily E Coates, Jason G Gall

Nat Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency.
Cindy X Cai, Nicole A Doria-Rose, Nicole A Schneck, Vera B Ivleva, Brad Tippett, Jason G Gall

Sci Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.
Katherine V Houser, Grace L Chen, Cristina Carter, Michelle C Crank, Thuy A Nguyen, Jason G Gall

Nat Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial.
Tracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, Michelle C Crank, Pamela J Costner, Jason G Gall

Lancet Respir Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Monoclonal Antibody for Malaria Prevention.
Martin R Gaudinski, Nina M Berkowitz, Azza H Idris, Emily E Coates, LaSonji A Holman, Jason G Gall

N Engl J Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proof of concept for structure-based vaccine design targeting RSV in humans.
Michelle C Crank, Tracy J Ruckwardt, Man Chen, Kaitlyn M Morabito, Emily Phung, Jason G Gall

Science· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis